Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

382
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
382
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

450
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
450
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

565
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
565
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

543
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
543
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

353
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
353
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

555
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
555

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Five Essential Concepts of Developmental Medicine: A Medical Paradigm for People with Developmental Disabilities.

Southern medical journal·2026
Same author

Time to extracorporeal cardiopulmonary resuscitation flow and outcomes in paediatric in-hospital cardiac arrest: a 12-year single-centre study.

Resuscitation plus·2026
Same author

Integrating 'What Matters' conversations into preoperative care: a qualitative evaluation of surgical team workflows and barriers.

BMJ quality & safety·2026
Same author

Single-session endoscopic retrograde cholangiopancreatography and endoscopic ultrasound-guided gallbladder drainage for management of biliary obstruction and gallbladder disease.

iGIE : innovation, investigation and insights·2026
Same author

Management of critical illness in an adolescent caused by highly pathogenic avian influenza A(H5N1) virus infection in British Columbia, Canada.

The Lancet. Infectious diseases·2026
Same author

A Multicenter Analysis of Factors Predicting Treatment Success for Intrapleural Enzyme Therapy for Pleural Infection.

Journal of bronchology & interventional pulmonology·2025

Related Experiment Video

Updated: Oct 12, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

626

A Primary Care Approach to Constipation in Adults with Intellectual and Developmental Disabilities.

Reshmi Mathew1, Barrett O Attarha1, Govind Kallumkal2

  • 1University of Florida College of Medicine, Jacksonville, USA.

Advances in Medicine
|November 25, 2021
PubMed
Summary

Constipation affects up to 40% of individuals with intellectual and developmental disabilities (IDD). Early diagnosis and individualized treatment are crucial to prevent severe health complications in this population.

More Related Videos

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

2.2K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.1K

Related Experiment Videos

Last Updated: Oct 12, 2025

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
04:04

Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation

Published on: July 5, 2024

626
Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
03:50

Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease

Published on: August 18, 2023

2.2K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.1K

Area of Science:

  • Medical Science
  • Gastroenterology
  • Developmental Disabilities

Background:

  • Constipation is highly prevalent in individuals with intellectual and developmental disabilities (IDD), affecting up to 40% of this population.
  • Common causes include neuromuscular issues, immobility, poor diet, and medication side effects.
  • Diagnostic challenges arise from communication barriers in adults with IDD, increasing the risk of missed diagnoses.

Purpose of the Study:

  • To highlight the prevalence and challenges of diagnosing constipation in individuals with IDD.
  • To emphasize the severe consequences of untreated constipation in this vulnerable group.
  • To advocate for an individualized approach to managing constipation in patients with IDD.

Main Methods:

  • Literature review on constipation in IDD.
  • Analysis of common contributing factors and diagnostic hurdles.
  • Review of potential adverse outcomes and treatment strategies.

Main Results:

  • Constipation is a significant issue in individuals with IDD, often multifactorial.
  • Communication barriers frequently impede accurate and timely diagnosis.
  • Inadequate treatment can lead to serious complications, including impaction, obstruction, and sepsis.

Conclusions:

  • A high index of suspicion is essential for diagnosing constipation in patients with IDD.
  • Individualized treatment plans are necessary to effectively manage constipation and mitigate associated risks.
  • Addressing constipation proactively can prevent severe health complications and improve patient outcomes.